Anđelka Ćelić
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Anđelka Ćelić has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Edward T. Petri
Department of Biology and Ecology, Faculty of Sciences, University of Novi Sad, Trg Dositeja Obradovića 2, 21000 Novi Sad, Serbia
11 shared publications - Sofija Bekić
Department of Chemistry, Biochemistry and Environmental Protection, Faculty of Sciences, University of Novi Sad, 21000 Novi Sad, Serbia
10 shared publications - Marija Sakač
Department of Chemistry, Biochemistry and Environmental Protection, Faculty of Sciences, University of Novi Sad, Trg Dositeja Obradovića 3, 21000 Novi Sad, Serbia
5 shared publications - Ivana Z. Kuzminac
Department of Chemistry, Biochemistry and Environmental Protection, Faculty of Sciences, University of Novi Sad, Trg Dositeja Obradovića 3, Novi Sad, Serbia
3 shared publications Maja A. Marinović
Faculty of Sciences, Department of Biology and Ecology, University of Novi Sad, Trg Dositeja Obradovića 2, 21000 Novi Sad, Serbia
3 shared publicationsSofija S. Bekić
Faculty of Sciences, Department of Chemistry, Biochemistry and Environmental Protection, University of Novi Sad, Trg Dositeja Obradovića 3, 21000 Novi Sad, Serbia
3 shared publications
Latest Publications
- 17 June 2026
- Published by Wiley in New Zealand Journal of Botany
- Vol. 64 (2)
First Evidence of Aldo–Keto Reductase Inhibition and Selective Steroid Receptor Binding by Polyphenols From Fistulina hepatica
To evaluate the bioactivity of Fistulina hepatica , 70% ethanolic (70% EtOH) and hot water (H 2 O) extracts were examined for interactions with steroid‐regulated pathways relevant to metabolic and hormone‐dependent disorders. Binding to estrogen (ERα, ERβ), androgen (AR), and glucocorticoid (GR) receptors, as well as inhibition of aldo–keto reductases AKR1C3 and AKR1C4, was assessed. Neither extract showed ER or AR binding, whereas selective GR binding was observed, with the 70% EtOH extract displaying the highest affinity, comparable to prednisolone. Both extracts inhibited AKR1C3 and AKR1C4, with the H 2 O extract exhibiting the strongest dual inhibition, in some cases exceeding ibuprofen. Multivariate and correlation analyses revealed strong associations between chlorogenic acid, quinic acid, and amentoflavone and all biological targets, indicating synergistic, multitarget effects rather than direct hormone receptor modulation. These findings highlight F. hepatica as a promising natural source of bioactive compounds with nutraceutical and therapeutic potential.
- 17 June 2026
- Published by Wiley in New Zealand Journal of Botany
- Vol. 64 (2)
First Evidence of Aldo–Keto Reductase Inhibition and Selective Steroid Receptor Binding by Polyphenols From Fistulina hepatica
To evaluate the bioactivity of Fistulina hepatica , 70% ethanolic (70% EtOH) and hot water (H 2 O) extracts were examined for interactions with steroid‐regulated pathways relevant to metabolic and hormone‐dependent disorders. Binding to estrogen (ERα, ERβ), androgen (AR), and glucocorticoid (GR) receptors, as well as inhibition of aldo–keto reductases AKR1C3 and AKR1C4, was assessed. Neither extract showed ER or AR binding, whereas selective GR binding was observed, with the 70% EtOH extract displaying the highest affinity, comparable to prednisolone. Both extracts inhibited AKR1C3 and AKR1C4, with the H 2 O extract exhibiting the strongest dual inhibition, in some cases exceeding ibuprofen. Multivariate and correlation analyses revealed strong associations between chlorogenic acid, quinic acid, and amentoflavone and all biological targets, indicating synergistic, multitarget effects rather than direct hormone receptor modulation. These findings highlight F. hepatica as a promising natural source of bioactive compounds with nutraceutical and therapeutic potential.
- 26 May 2026
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 107 (5) , e70321
Novel 10‐Alkoxy 1,4‐Dien‐3‐One Estranes as Multitarget Anticancer Agents Against Estrogen‐Positive Breast Cancer
Breast cancer remains the most prevalent cancer among women, driving the continuous search for novel anticancer agents. In this study, a series of 10‐alkoxy steroids containing a 1,4‐dien‐3‐one moiety was synthesized via a one‐step dearomatization of the A‐ring of estradiol and an estrane derivative with a D‐homo lactone moiety. All compounds exhibited favorable in silico ADMET properties, while five derivatives showed significant cytotoxic activity in vitro. The strongest effects against the estrogen‐positive breast cancer cell line MCF‐7 were observed for two 10β‐methoxy, one 10β‐butoxy, and two 10β‐propargyloxy derivatives. The activity of the 10β‐butoxy‐17β‐hydroxy and 10β‐propargyloxy‐17β‐hydroxy steroids correlates with strong binding affinity toward estrogen receptor α and inhibition of AKR1C3 and AKR1C4 enzymatic activity. Additionally, the propargyloxy derivative showed substrate‐like binding to human recombinant aromatase. Molecular docking results are in qualitative agreement with these findings, predicting binding modes similar to known ligands and possible hydrophobic interactions between the C‐10 alkoxy groups and the active sites of target proteins, particularly the heme group of aromatase. These results highlight novel estrane derivatives as promising candidates for estrogen‐positive breast cancer therapy through combined effects involving AKR1C3 inhibition and interaction with aromatase and estrogen receptor.
- 26 May 2026
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 107 (5) , e70321
Novel 10‐Alkoxy 1,4‐Dien‐3‐One Estranes as Multitarget Anticancer Agents Against Estrogen‐Positive Breast Cancer
Breast cancer remains the most prevalent cancer among women, driving the continuous search for novel anticancer agents. In this study, a series of 10‐alkoxy steroids containing a 1,4‐dien‐3‐one moiety was synthesized via a one‐step dearomatization of the A‐ring of estradiol and an estrane derivative with a D‐homo lactone moiety. All compounds exhibited favorable in silico ADMET properties, while five derivatives showed significant cytotoxic activity in vitro. The strongest effects against the estrogen‐positive breast cancer cell line MCF‐7 were observed for two 10β‐methoxy, one 10β‐butoxy, and two 10β‐propargyloxy derivatives. The activity of the 10β‐butoxy‐17β‐hydroxy and 10β‐propargyloxy‐17β‐hydroxy steroids correlates with strong binding affinity toward estrogen receptor α and inhibition of AKR1C3 and AKR1C4 enzymatic activity. Additionally, the propargyloxy derivative showed substrate‐like binding to human recombinant aromatase. Molecular docking results are in qualitative agreement with these findings, predicting binding modes similar to known ligands and possible hydrophobic interactions between the C‐10 alkoxy groups and the active sites of target proteins, particularly the heme group of aromatase. These results highlight novel estrane derivatives as promising candidates for estrogen‐positive breast cancer therapy through combined effects involving AKR1C3 inhibition and interaction with aromatase and estrogen receptor.
- 18 October 2024
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 16 (1) , 232-246
Synthesis and biological evaluation of novel D-ring fused steroidal N (2)-substituted-1,2,3-triazoles
In this study, a series of 13 new D-ring fused steroidal N (2)-substituted-1,2,3-triazoles were synthesized, characterized and evaluated for their biological activities.
- 18 October 2024
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 16 (1) , 232-246
Synthesis and biological evaluation of novel D-ring fused steroidal N (2)-substituted-1,2,3-triazoles
In this study, a series of 13 new D-ring fused steroidal N (2)-substituted-1,2,3-triazoles were synthesized, characterized and evaluated for their biological activities.
- Open Access
- 20 June 2024
- Published by Slovenian Chemical Society in Acta Chimica Slovenica
- Vol. 71 (2) , 256-263
Expression and Purification of Active Human 17β-Hydroxysteroid Dehydrogenase Type 1 from Escherichia coli
Acta Chimica Slovenica (ACSi) provides a forum for the publication of original and significant work in the chemical and closely related areas of research. Reviews, scientific and technical articles, and short communications are welcome.
- 20 June 2024
- Published by Slovenian Chemical Society in Acta Chimica Slovenica
- Vol. 71 (2) , 256-263
Open AccessExpression and Purification of Active Human 17β-Hydroxysteroid Dehydrogenase Type 1 from Escherichia coli
Acta Chimica Slovenica (ACSi) provides a forum for the publication of original and significant work in the chemical and closely related areas of research. Reviews, scientific and technical articles, and short communications are welcome.
- 17 April 2024
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 16 (11) , 1127-1145
Synthesis, in vitro and in silico anticancer evaluation of novel pyridin-2-yl estra-1,3,5(10)-triene derivatives
Aim: The aim of this study was the synthesis of steroid compounds with heterocyclic rings and good anticancer properties. Materials & methods: The synthesis, in silico and in vitro anticancer testi... Tweetable abstract The series of pyridine-containing estra-1,3,5(10)-triene derivatives was synthesized. One novel derivative stood out by its excellent activity against the MDA-MB-231 cell line. T... Graphical abstract
- 17 April 2024
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 16 (11) , 1127-1145
Synthesis, in vitro and in silico anticancer evaluation of novel pyridin-2-yl estra-1,3,5(10)-triene derivatives
Aim: The aim of this study was the synthesis of steroid compounds with heterocyclic rings and good anticancer properties. Materials & methods: The synthesis, in silico and in vitro anticancer testi... Tweetable abstract The series of pyridine-containing estra-1,3,5(10)-triene derivatives was synthesized. One novel derivative stood out by its excellent activity against the MDA-MB-231 cell line. T... Graphical abstract
- 4 April 2024
- Published by Elsevier in Analytical Biochemistry
- Vol. 690, 115529
Detection of isoflavones and phytoestrogen-rich plant extracts binding to estrogen receptor β using a yeast-based fluorescent assay
- 4 April 2024
- Published by Elsevier in Analytical Biochemistry
- Vol. 690, 115529
Detection of isoflavones and phytoestrogen-rich plant extracts binding to estrogen receptor β using a yeast-based fluorescent assay
- Open Access
- 1 January 2023
- Published by National Library of Serbia in Journal of the Serbian Chemical Society
- Vol. 88 (2) , 123-139
Screening the binding affinity of bile acid derivatives for the glucocorticoid receptor ligand-binding domain
The necessity of anti-inflammatory drugs such as glucocorticoids has been evident during the COVID-19 pandemic. Glucocorticoids, are the standard therapy for the treatment of moderate and severe COVID-19 patients. However, serious side effects limit the use of these drugs, and anti-inflammatory drugs with better pharmacological properties are urgently required. Bile acids are of interest, because of their anti-inflammatory and immunomodulatory properties, facilitated through an unclear mechanism involving transmembrane and nuclear receptors. In this work, we screened the binding activity of a number of bile acid derivatives, for the ligand-binding domain of glucocorticoid receptor (GR-LBD), the most important receptor for anti-inflammatory processes. Tested compounds include oximes, lactones, lactams, tetrazoles, dienones, C-24 alcohols and cholic acid amides. Cholic acid oxime, deoxycholic acid dienone, 3-keto-24-cholic alcohol and cholic acid amide showed best binding affinities for GR-LBD among tested compounds. The in silico molecular docking explanation is provided. SAR analysis showed that expansion of B and C steroid rings or attachment of heterocycle to C ring is not beneficial for binding; side chain should contain hydrogen donor group; the GR-LBD tolerate well different functionalities on C-3 position. These results provide valuable information toward synthesis of the new glucocorticoids based on bile acids.
- 1 January 2023
- Published by National Library of Serbia in Journal of the Serbian Chemical Society
- Vol. 88 (2) , 123-139
Open AccessScreening the binding affinity of bile acid derivatives for the glucocorticoid receptor ligand-binding domain
The necessity of anti-inflammatory drugs such as glucocorticoids has been evident during the COVID-19 pandemic. Glucocorticoids, are the standard therapy for the treatment of moderate and severe COVID-19 patients. However, serious side effects limit the use of these drugs, and anti-inflammatory drugs with better pharmacological properties are urgently required. Bile acids are of interest, because of their anti-inflammatory and immunomodulatory properties, facilitated through an unclear mechanism involving transmembrane and nuclear receptors. In this work, we screened the binding activity of a number of bile acid derivatives, for the ligand-binding domain of glucocorticoid receptor (GR-LBD), the most important receptor for anti-inflammatory processes. Tested compounds include oximes, lactones, lactams, tetrazoles, dienones, C-24 alcohols and cholic acid amides. Cholic acid oxime, deoxycholic acid dienone, 3-keto-24-cholic alcohol and cholic acid amide showed best binding affinities for GR-LBD among tested compounds. The in silico molecular docking explanation is provided. SAR analysis showed that expansion of B and C steroid rings or attachment of heterocycle to C ring is not beneficial for binding; side chain should contain hydrogen donor group; the GR-LBD tolerate well different functionalities on C-3 position. These results provide valuable information toward synthesis of the new glucocorticoids based on bile acids.
- Open Access
- 1 December 2022
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 14 (2) , 341-355
X-ray structure of human aldo–keto reductase 1C3 in complex with a bile acid fused tetrazole inhibitor: experimental validation, molecular docking and structural analysis
Steroid bile acid fused tetrazoles were screened for ability to inhibit aldo–keto reductase 1C3 (AKR1C3), a target for cancer treatment. The X-ray structure of AKR1C3 in complex with a bile acid tetrazole inhibitor is presented.
- 1 December 2022
- Published by Royal Society of Chemistry (RSC) in RSC Medicinal Chemistry
- Vol. 14 (2) , 341-355
Open AccessX-ray structure of human aldo–keto reductase 1C3 in complex with a bile acid fused tetrazole inhibitor: experimental validation, molecular docking and structural analysis
Steroid bile acid fused tetrazoles were screened for ability to inhibit aldo–keto reductase 1C3 (AKR1C3), a target for cancer treatment. The X-ray structure of AKR1C3 in complex with a bile acid tetrazole inhibitor is presented.
- Open Access
- 1 November 2022
- Published by MDPI AG in Medical Sciences Forum
- Vol. 14 (1) , 40
Identification of Novel ERβ Ligands
The estrogen receptor (ER) is a major therapeutic target in treating estrogen-related diseases, such as breast cancer. There is a need to develop potent ER ligands capable of selectively targeting cancer cells without affecting normal cells. Blocking ERα action by antagonists and inhibiting steroidogenic enzymes has been standard therapy in breast cancer treatment for many years. On the other hand, the ERβ isoform usually has antiproliferative and tumor-suppressive functions, so targeting ERβ with specific agonists represents a promising new approach not only in breast cancer but also in prostate cancer therapy. Besides the anticancer activity of ERβ agonists, their application is considered in treating depression, anxiety, and inflammation. To obtain potent antiproliferative agents, a triazole ring is often incorporated as a pharmacophore in the steroid skeleton. This study evaluates the binding affinity of novel N(2)-substituted D-condensed steroidal triazoles for ligand-binding domains (LBDs) of ERβ and androgen receptors using a yeast-based fluorescent assay. The LBD of the steroid receptor was expressed in-frame with a yellow fluorescent protein (YFP) in Saccharomyces cerevisiae. Upon ligand-binding induced dimerization, fluorescence resonance energy transfer (FRET) between YFP molecules was analyzed using fluorescence spectroscopy and microscopy. We identified new selective ERβ ligands without androgenic properties, but further experiments are required to determine whether their mechanism of action is agonistic or antagonistic. Considering the broad therapeutic potential of specific ERβ ligands, our findings indicate that steroid derivatives containing triazole are promising bioactive compounds in the field of anticancer agents.
- 1 November 2022
- Published by MDPI AG in Medical Sciences Forum
- Vol. 14 (1) , 40
Open AccessIdentification of Novel ERβ Ligands
The estrogen receptor (ER) is a major therapeutic target in treating estrogen-related diseases, such as breast cancer. There is a need to develop potent ER ligands capable of selectively targeting cancer cells without affecting normal cells. Blocking ERα action by antagonists and inhibiting steroidogenic enzymes has been standard therapy in breast cancer treatment for many years. On the other hand, the ERβ isoform usually has antiproliferative and tumor-suppressive functions, so targeting ERβ with specific agonists represents a promising new approach not only in breast cancer but also in prostate cancer therapy. Besides the anticancer activity of ERβ agonists, their application is considered in treating depression, anxiety, and inflammation. To obtain potent antiproliferative agents, a triazole ring is often incorporated as a pharmacophore in the steroid skeleton. This study evaluates the binding affinity of novel N(2)-substituted D-condensed steroidal triazoles for ligand-binding domains (LBDs) of ERβ and androgen receptors using a yeast-based fluorescent assay. The LBD of the steroid receptor was expressed in-frame with a yellow fluorescent protein (YFP) in Saccharomyces cerevisiae. Upon ligand-binding induced dimerization, fluorescence resonance energy transfer (FRET) between YFP molecules was analyzed using fluorescence spectroscopy and microscopy. We identified new selective ERβ ligands without androgenic properties, but further experiments are required to determine whether their mechanism of action is agonistic or antagonistic. Considering the broad therapeutic potential of specific ERβ ligands, our findings indicate that steroid derivatives containing triazole are promising bioactive compounds in the field of anticancer agents.